Bolt Biotherapeutics has announced the acquisition of fellow USA-based Prana Therapies, a clinical-stage biotechnology company pioneering next-generation half-life-extended multispecific antibodies ...
The European Commission has approved an indication extension for Johnson & Johnson's Tecvayli (teclistamab) as monotherapy ...
Danish drugmaker Novo (NOV: N) and US pharma major Eli Lilly (NYSE: LLY) are competing across a widening range of obesity ...
Zymeworks, the Vancouver-based biotech, has signed an exclusive global license and collaboration agreement with Roche for ...
Shares in UCB, the Belgian biopharma company, closed 21.6% higher at 259.10 euros on Thursday after it raised its 2026 ...
Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely ...
US pharma major Merck & Co (NYSE: MRK) and US biotech Moderna (Nasdaq: MRNA) have reported detailed Phase III results showing ...
US pharma major AbbVie yesterday announced positive top-line results from the Phase III INTREPID study evaluating the safety ...
Pharmaceutical companies’ reliance on Chinese suppliers extends from early laboratory work to the production of medicines for ...
The US Treasury Department has proposed adding biotech to the sectors covered by its outbound investment rules, a move that ...
Danish clinical-stage techbio Evaxion has announced new three-year immune and clinical outcome data for personalized cancer ...
Gilead Sciences revealed it has entered into a definitive agreement to acquire an oral interleukin (IL)-23R inhibitor program ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results